5AM Ventures IV, L.P.

5AM Ventures IV, L.P. is a declared insider at 4 companies; the most frequent names are Crinetics Pharmaceuticals, Inc., Q32 Bio Inc. and Aprea Therapeutics, Inc. The record holds 61 filings, for trades running from 2 April 2018 to 22 December 2020.

On the open market, the record shows 6 purchases worth €12.9M and 31 sales worth €77.2M. Sales outweigh purchases by €64.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2020, the count stands at no purchases and 17 sales.

Half of the purchases are above €1.9M and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -47.7%. They describe history only and say nothing certain about the share price ahead.

On 28 December 2020 came the latest disclosure, an open-market sale for €5.0M in Q32 Bio Inc. The last insider purchase was made public on 9 October 2019, 2,587 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.